State Street Corp Incyte Corp Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Incyte Corp stock. As of the latest transaction made, State Street Corp holds 9,875,758 shares of INCY stock, worth $821 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

9,875,758

Previous 10,035,460 1.59%

Holding current value

$821 Million

Previous $608 Million 10.68%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$55.17 - $71.22 $8.81 Million - $11.4 Million	-159,702 Reduced 1.59%	9,875,758 $673 Million
Q1 2025 May 15, 2025	BUY	$60.0 - $75.26 $259,440 - $325,424	4,324 Added 0.04%	10,035,460 $608 Million
Q4 2024 Feb 14, 2025	SELL	$65.08 - $83.38 $33.9 Million - $43.4 Million	-520,143 Reduced 4.93%	10,031,136 $693 Million
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $17.2 Million - $20.6 Million	-300,240 Reduced 2.77%	10,551,279 $697 Million
Q2 2024 Aug 14, 2024	BUY	$51.18 - $63.75 $48.7 Million - $60.7 Million	951,973 Added 9.62%	10,851,519 $658 Million
Q1 2024 May 15, 2024	SELL	$56.55 - $66.59 $12.5 Million - $14.7 Million	-220,624 Reduced 2.18%	9,899,546 $564 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $31.8 Million - $39.1 Million	609,140 Added 6.4%	10,120,170 $635 Million
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $19.6 Million - $22.4 Million	-339,425 Reduced 3.45%	9,511,030 $549 Million
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $32.1 Million - $39.8 Million	527,398 Added 5.66%	9,850,455 $613 Million
Q1 2023 May 15, 2023	SELL	$70.23 - $86.01 $7.75 Million - $9.49 Million	-110,307 Reduced 1.17%	9,323,057 $674 Million
Q4 2022 Feb 14, 2023	SELL	$67.18 - $84.11 $8.03 Million - $10.1 Million	-119,589 Reduced 1.25%	9,433,364 $758 Million
Q3 2022 Nov 15, 2022	BUY	$66.18 - $82.86 $6.62 Million - $8.29 Million	100,077 Added 1.06%	9,552,953 $637 Million
Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $13.1 Million - $16.5 Million	198,104 Added 2.14%	9,452,876 $718 Million
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $6.14 Million - $7.41 Million	-92,937 Reduced 0.99%	9,254,772 $735 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $24.6 Million - $28.8 Million	388,337 Added 4.33%	9,347,709 $686 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $35.6 Million - $43.5 Million	517,993 Added 6.14%	8,959,372 $616 Million
Q2 2021 Aug 16, 2021	BUY	$79.87 - $87.53 $7.2 Million - $7.89 Million	90,130 Added 1.08%	8,441,379 $710 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $25.7 Million - $34 Million	-337,876 Reduced 3.89%	8,351,249 $679 Million
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $2.88 Million - $3.48 Million	-35,651 Reduced 0.41%	8,689,125 $756 Million
Q3 2020 Nov 10, 2020	BUY	$85.07 - $109.69 $20.5 Million - $26.4 Million	240,533 Added 2.84%	8,724,776 $783 Million
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $8.49 Million - $12.5 Million	114,422 Added 1.37%	8,484,243 $882 Million
Q1 2020 May 11, 2020	BUY	$63.18 - $85.97 $529 Million - $720 Million	8,369,821 New	8,369,821 $613 Million

Others Institutions Holding INCY

# of Institutions

730

Shares Held

202M

Call Options Held

516K

Put Options Held

265K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $18.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Incyte Corp Transaction History